scispace - formally typeset
R

Ralph B. D'Agostino

Researcher at Wake Forest University

Publications -  1336
Citations -  250792

Ralph B. D'Agostino is an academic researcher from Wake Forest University. The author has contributed to research in topics: Framingham Heart Study & Framingham Risk Score. The author has an hindex of 226, co-authored 1287 publications receiving 229636 citations. Previous affiliations of Ralph B. D'Agostino include VA Boston Healthcare System & University of Illinois at Urbana–Champaign.

Papers
More filters
Journal ArticleDOI

Hypertension, antihypertensive treatment, and sudden coronary death. The Framingham Study.

TL;DR: Multivariate analysis taking into account the level of blood pressure, electrocardiographic abnormalities, and previously diagnosed coronary heart disease and cardiac failure indicated a persistent increased risk of sudden death hi association with antihypertensive treatment.
Journal ArticleDOI

Determinants of the Thrombogenic Potential of Multiwalled Carbon Nanotubes

TL;DR: It is concluded that the procoagulant tendencies of MWCNTs observed in vitro are not necessarily recapitulated in vivo, which will inform the rational development of biocompatible M WCNTs for systemic delivery.
Journal ArticleDOI

A Human Bone Morphogenetic Protein Antagonist Is Down-Regulated in Renal Cancer

TL;DR: Results demonstrate that SOSTDC1 is expressed in the human kidney and decreased in renal clear cell carcinoma, and restoration of SOST DC1 signaling may represent a novel target in treatment of renal clear carcinoma.
Journal ArticleDOI

Dietary Patterns and the Odds of Carotid Atherosclerosis in Women: The Framingham Nutrition Studies

TL;DR: The association among unique dietary patterns, CVD risk factor profiles, and the presence of subclinical atherosclerosis identifies candidates and strategies for preventive behavioral interventions to promote the primary prevention of heart disease.
Journal ArticleDOI

Meta-analysis: A method for synthesizing research

TL;DR: It is necessary to select patients suitable for vaginal or laparoscopic mesh placement for intranasal administration based on prior history and once they provide informed consent for surgery.